Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 20, 2020 10:00 ET | Source: Vyriad

Vyriad Announces Initiation of Phase 2 Trial in Multiple Cancer Indications

ROCHESTER, Minn., July 20, 2020 (GLOBE NEWSWIRE) -- Vyriad, Inc. announced today the dosing of the first patient in a Phase 2 clinical trial to evaluate its investigational oncolytic virus...